Chris Atim, Ph.D., is a health economist with more than 25 years of experience working on health-systems financing worldwide. He is an executive with Results for Development and the founding executive director of the African Health Economics and Policy Association.

Chris Beyrer, M.D., MPH, is the inaugural Desmond M. Tutu professor in public health and human rights and professor at Johns Hopkins University. From 2014-16, he served as president at the International AIDS Society. Beyrer has extensive experience in conducting international collaborative research and has spent much of his career focusing on health and human rights.

Chris Chibwana is a partner and African lead at IDinsight, based in Lusaka, Zambia. He oversees IDinsight’s Africa client engagements, which encompass projects across social protection, education, agriculture, health and water, and sanitation sectors.

Chris Collins is president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria where he leads the organization's efforts in Washington, D.C., to secure investment in the Global Fund and related global health programs. With more than 20 years of experience working in HIV advocacy and policy, he previously headed mobilization efforts at UNAIDS in Geneva, and led amfAR’s policy work in Washington. Chris holds a master’s degree in public policy from Harvard University.

Chris Elias, MD, MPH, is president of the Global Development Program of the Bill & Melinda Gates Foundation. He leads the foundation’s efforts to accelerate the delivery of proven health care products and solutions to those who need them most — especially women and children. Chris recently served as the president and CEO of PATH, an international nonprofit organization dedicated to improving the health of people around the world by developing innovative health technologies, strengthening health care systems, and encouraging healthy behaviors.

Chris is a fellow of the Australian Institute of Company Directors with over 18 years governance experience, currently serving as chair of RESULTS International Australia and previously as a director and chair of not-for-profit, government, financial services, personal insurance, and health insurance boards.

Chris Gegenheimer is Chemonics’ director for monitoring, evaluation and learning rechnology and leads efforts in rolling out new data collection, management, analysis, and visualization technologies across home and project offices. Since joining Chemonics Mr. Gegenheimer has been in the MEL department supporting proposal and project teams in Latin America and the Caribbean, Asia, Africa, and the Middle East.

Chris Gray is head of environmental, social, and governance strategy and operations at Pfizer Inc. He is responsible for developing and implementing an enterprisewide approach to enhance ESG performance metrics and outcomes, co-chairs the Sustainability Steering Committee, and leads efforts to embed the ESG discipline into Pfizer business strategies. He also leads external ESG engagement and efforts to align Pfizer’s Purpose and ESG strategy with the Sustainable Development Goals and works closely with governments and civil society on strategic initiatives to improve global health and development.

Chris Humphrey is a senior research associate at the ODI global affairs think tank and senior scientist at ETH Zurich NADEL Center for Development and Cooperation.